Primary study · included by 1 review

Plasma antibodies to oral bacteria and risk of pancreatic cancer in a large European prospective cohort study.

Michaud 2013 · Michaud Dominique S, Izard Jacques, Wilhelm-Benartzi Charlotte S, et al. · Gut · 2013

Included by

Non-Cochrane · aetiology · 2026 · cited as Michaud 2013 · Table 1; Figure 3; reference list

Outcome this study informs	Pooled effect	Evidence	Certainty
Pancreatic cancer incidence or risk Periodontitis (clinical, radiographic, self-reported, registry diagnosis or tooth loss attributable to periodontal disease) vs No periodontitis or healthy/mild periodontal status	logHR 0.44 [-0.18, 1.06]	2 studies	GRADE not reported
Pancreatic cancer incidence or risk Periodontitis (clinical, radiographic, self-reported, registry diagnosis or tooth loss attributable to periodontal disease) vs No periodontitis or healthy/mild periodontal status	HR 1.56 [1.28, 1.89]	8 studies · 476245 participants	Very low
Pancreatic cancer incidence or risk Periodontitis (clinical, radiographic, self-reported, registry diagnosis or tooth loss attributable to periodontal disease) vs No periodontitis or healthy/mild periodontal status	logHR 0.45 [0.20, 0.71]	2 studies	GRADE not reported
Pancreatic cancer incidence or risk Periodontitis (clinical, radiographic, self-reported, registry diagnosis or tooth loss attributable to periodontal disease) vs No periodontitis or healthy/mild periodontal status	logHR 0.53 [0.29, 0.76]	4 studies	GRADE not reported

1 including review in total.